Even as Carl Icahn continues his public fight to acquire Clorox (CLX), many arbitrage traders...

|About: The Clorox Company (CLX)|By:, SA News Editor

Even as Carl Icahn continues his public fight to acquire Clorox (CLX), many arbitrage traders are giving him low odds of pulling off a deal, in part due to Icahn's offer being contingent on a complete board overhaul. In addition, there's plenty of analyst and investor skepticism about a third party such UL or PG buying Clorox.